Cargando…

Optimal symptom combinations to aid COVID-19 case identification: Analysis from a community-based, prospective, observational cohort

OBJECTIVES: Diagnostic work-up following any COVID-19 associated symptom will lead to extensive testing, potentially overwhelming laboratory capacity whilst primarily yielding negative results. We aimed to identify optimal symptom combinations to capture most cases using fewer tests with implication...

Descripción completa

Detalles Bibliográficos
Autores principales: Antonelli, M., Capdevila, J., Chaudhari, A., Granerod, J., Canas, L.S., Graham, M.S., Klaser, K., Modat, M., Molteni, E., Murray, B., Sudre, C.H., Davies, R., May, A., Nguyen, L.H., Drew, D.A., Joshi, A., Chan, A.T., Cramer, J.P., Spector, T., Wolf, J., Ourselin, S., Steves, C.J., Loeliger, A.E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Published by Elsevier Ltd on behalf of The British Infection Association. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7881291/
https://www.ncbi.nlm.nih.gov/pubmed/33592254
http://dx.doi.org/10.1016/j.jinf.2021.02.015
_version_ 1783650848928169984
author Antonelli, M.
Capdevila, J.
Chaudhari, A.
Granerod, J.
Canas, L.S.
Graham, M.S.
Klaser, K.
Modat, M.
Molteni, E.
Murray, B.
Sudre, C.H.
Davies, R.
May, A.
Nguyen, L.H.
Drew, D.A.
Joshi, A.
Chan, A.T.
Cramer, J.P.
Spector, T.
Wolf, J.
Ourselin, S.
Steves, C.J.
Loeliger, A.E.
author_facet Antonelli, M.
Capdevila, J.
Chaudhari, A.
Granerod, J.
Canas, L.S.
Graham, M.S.
Klaser, K.
Modat, M.
Molteni, E.
Murray, B.
Sudre, C.H.
Davies, R.
May, A.
Nguyen, L.H.
Drew, D.A.
Joshi, A.
Chan, A.T.
Cramer, J.P.
Spector, T.
Wolf, J.
Ourselin, S.
Steves, C.J.
Loeliger, A.E.
author_sort Antonelli, M.
collection PubMed
description OBJECTIVES: Diagnostic work-up following any COVID-19 associated symptom will lead to extensive testing, potentially overwhelming laboratory capacity whilst primarily yielding negative results. We aimed to identify optimal symptom combinations to capture most cases using fewer tests with implications for COVID-19 vaccine developers across different resource settings and public health. METHODS: UK and US users of the COVID-19 Symptom Study app who reported new-onset symptoms and an RT-PCR test within seven days of symptom onset were included. Sensitivity, specificity, and number of RT-PCR tests needed to identify one case (test per case [TPC]) were calculated for different symptom combinations. A multi-objective evolutionary algorithm was applied to generate combinations with optimal trade-offs between sensitivity and specificity. FINDINGS: UK and US cohorts included 122,305 (1,202 positives) and 3,162 (79 positive) individuals. Within three days of symptom onset, the COVID-19 specific symptom combination (cough, dyspnoea, fever, anosmia/ageusia) identified 69% of cases requiring 47 TPC. The combination with highest sensitivity (fatigue, anosmia/ageusia, cough, diarrhoea, headache, sore throat) identified 96% cases requiring 96 TPC. INTERPRETATION: We confirmed the significance of COVID-19 specific symptoms for triggering RT-PCR and identified additional symptom combinations with optimal trade-offs between sensitivity and specificity that maximize case capture given different resource settings.
format Online
Article
Text
id pubmed-7881291
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Published by Elsevier Ltd on behalf of The British Infection Association.
record_format MEDLINE/PubMed
spelling pubmed-78812912021-02-16 Optimal symptom combinations to aid COVID-19 case identification: Analysis from a community-based, prospective, observational cohort Antonelli, M. Capdevila, J. Chaudhari, A. Granerod, J. Canas, L.S. Graham, M.S. Klaser, K. Modat, M. Molteni, E. Murray, B. Sudre, C.H. Davies, R. May, A. Nguyen, L.H. Drew, D.A. Joshi, A. Chan, A.T. Cramer, J.P. Spector, T. Wolf, J. Ourselin, S. Steves, C.J. Loeliger, A.E. J Infect Commentary OBJECTIVES: Diagnostic work-up following any COVID-19 associated symptom will lead to extensive testing, potentially overwhelming laboratory capacity whilst primarily yielding negative results. We aimed to identify optimal symptom combinations to capture most cases using fewer tests with implications for COVID-19 vaccine developers across different resource settings and public health. METHODS: UK and US users of the COVID-19 Symptom Study app who reported new-onset symptoms and an RT-PCR test within seven days of symptom onset were included. Sensitivity, specificity, and number of RT-PCR tests needed to identify one case (test per case [TPC]) were calculated for different symptom combinations. A multi-objective evolutionary algorithm was applied to generate combinations with optimal trade-offs between sensitivity and specificity. FINDINGS: UK and US cohorts included 122,305 (1,202 positives) and 3,162 (79 positive) individuals. Within three days of symptom onset, the COVID-19 specific symptom combination (cough, dyspnoea, fever, anosmia/ageusia) identified 69% of cases requiring 47 TPC. The combination with highest sensitivity (fatigue, anosmia/ageusia, cough, diarrhoea, headache, sore throat) identified 96% cases requiring 96 TPC. INTERPRETATION: We confirmed the significance of COVID-19 specific symptoms for triggering RT-PCR and identified additional symptom combinations with optimal trade-offs between sensitivity and specificity that maximize case capture given different resource settings. Published by Elsevier Ltd on behalf of The British Infection Association. 2021-03 2021-02-13 /pmc/articles/PMC7881291/ /pubmed/33592254 http://dx.doi.org/10.1016/j.jinf.2021.02.015 Text en © 2021 Published by Elsevier Ltd on behalf of The British Infection Association. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Commentary
Antonelli, M.
Capdevila, J.
Chaudhari, A.
Granerod, J.
Canas, L.S.
Graham, M.S.
Klaser, K.
Modat, M.
Molteni, E.
Murray, B.
Sudre, C.H.
Davies, R.
May, A.
Nguyen, L.H.
Drew, D.A.
Joshi, A.
Chan, A.T.
Cramer, J.P.
Spector, T.
Wolf, J.
Ourselin, S.
Steves, C.J.
Loeliger, A.E.
Optimal symptom combinations to aid COVID-19 case identification: Analysis from a community-based, prospective, observational cohort
title Optimal symptom combinations to aid COVID-19 case identification: Analysis from a community-based, prospective, observational cohort
title_full Optimal symptom combinations to aid COVID-19 case identification: Analysis from a community-based, prospective, observational cohort
title_fullStr Optimal symptom combinations to aid COVID-19 case identification: Analysis from a community-based, prospective, observational cohort
title_full_unstemmed Optimal symptom combinations to aid COVID-19 case identification: Analysis from a community-based, prospective, observational cohort
title_short Optimal symptom combinations to aid COVID-19 case identification: Analysis from a community-based, prospective, observational cohort
title_sort optimal symptom combinations to aid covid-19 case identification: analysis from a community-based, prospective, observational cohort
topic Commentary
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7881291/
https://www.ncbi.nlm.nih.gov/pubmed/33592254
http://dx.doi.org/10.1016/j.jinf.2021.02.015
work_keys_str_mv AT antonellim optimalsymptomcombinationstoaidcovid19caseidentificationanalysisfromacommunitybasedprospectiveobservationalcohort
AT capdevilaj optimalsymptomcombinationstoaidcovid19caseidentificationanalysisfromacommunitybasedprospectiveobservationalcohort
AT chaudharia optimalsymptomcombinationstoaidcovid19caseidentificationanalysisfromacommunitybasedprospectiveobservationalcohort
AT granerodj optimalsymptomcombinationstoaidcovid19caseidentificationanalysisfromacommunitybasedprospectiveobservationalcohort
AT canasls optimalsymptomcombinationstoaidcovid19caseidentificationanalysisfromacommunitybasedprospectiveobservationalcohort
AT grahamms optimalsymptomcombinationstoaidcovid19caseidentificationanalysisfromacommunitybasedprospectiveobservationalcohort
AT klaserk optimalsymptomcombinationstoaidcovid19caseidentificationanalysisfromacommunitybasedprospectiveobservationalcohort
AT modatm optimalsymptomcombinationstoaidcovid19caseidentificationanalysisfromacommunitybasedprospectiveobservationalcohort
AT moltenie optimalsymptomcombinationstoaidcovid19caseidentificationanalysisfromacommunitybasedprospectiveobservationalcohort
AT murrayb optimalsymptomcombinationstoaidcovid19caseidentificationanalysisfromacommunitybasedprospectiveobservationalcohort
AT sudrech optimalsymptomcombinationstoaidcovid19caseidentificationanalysisfromacommunitybasedprospectiveobservationalcohort
AT daviesr optimalsymptomcombinationstoaidcovid19caseidentificationanalysisfromacommunitybasedprospectiveobservationalcohort
AT maya optimalsymptomcombinationstoaidcovid19caseidentificationanalysisfromacommunitybasedprospectiveobservationalcohort
AT nguyenlh optimalsymptomcombinationstoaidcovid19caseidentificationanalysisfromacommunitybasedprospectiveobservationalcohort
AT drewda optimalsymptomcombinationstoaidcovid19caseidentificationanalysisfromacommunitybasedprospectiveobservationalcohort
AT joshia optimalsymptomcombinationstoaidcovid19caseidentificationanalysisfromacommunitybasedprospectiveobservationalcohort
AT chanat optimalsymptomcombinationstoaidcovid19caseidentificationanalysisfromacommunitybasedprospectiveobservationalcohort
AT cramerjp optimalsymptomcombinationstoaidcovid19caseidentificationanalysisfromacommunitybasedprospectiveobservationalcohort
AT spectort optimalsymptomcombinationstoaidcovid19caseidentificationanalysisfromacommunitybasedprospectiveobservationalcohort
AT wolfj optimalsymptomcombinationstoaidcovid19caseidentificationanalysisfromacommunitybasedprospectiveobservationalcohort
AT ourselins optimalsymptomcombinationstoaidcovid19caseidentificationanalysisfromacommunitybasedprospectiveobservationalcohort
AT stevescj optimalsymptomcombinationstoaidcovid19caseidentificationanalysisfromacommunitybasedprospectiveobservationalcohort
AT loeligerae optimalsymptomcombinationstoaidcovid19caseidentificationanalysisfromacommunitybasedprospectiveobservationalcohort